Evidence map›Paper›PMID 37903095›Full record

ReviewChemical research in toxicology2023

Nontargeted Analysis in Tobacco Research: Challenges and Opportunities.

Ayomipo Adeniji, Rachel El-Hage, Marielle C Brinkman, Ahmad El-Hellani

Abstract readReview
In one paragraph

Review in Chemical research in toxicology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Ayomipo AdenijiDivision of Environmental Health Sciences, College of Public Health, The Ohio State University, Columbus, Ohio 43210, United States.
Rachel El-HageDepartment of Chemistry, Faculty of Arts and Sciences, American University of Beirut, Beirut 1107 2020, Lebanon.
Marielle C BrinkmanDivision of Epidemiology, College of Public Health, The Ohio State University, Columbus, Ohio 43210, United States.
Ahmad El-HellaniDivision of Environmental Health Sciences, College of Public Health, The Ohio State University, Columbus, Ohio 43210, United States.ORCID 0000-0002-1047-0597
The Ohio State University · USVirginia Commonwealth University · US

Funding

Nicotine flux, a potentially powerful tool for regulating nicotine delivery from electronic cigarettes: significance of nicotine flux to the rate of nicotine delivery and subjective effectsR01DA052565 · NIDA · AMERICAN UNIVERSITY OF BEIRUT · PI EL HELLANI, AHMAD, TALIH, SOHA · 2022 to 2024
$1.3M
NIDA NIH HHS R01 DA052565
6 · The paper itself

Abstract

Tobacco products are evolving at a pace that has outstripped tobacco control, leading to a high prevalence of tobacco use in the population. Researchers have been tirelessly developing suitable techniques to assess these products' emissions, toxicity, and public health impact. The nonclinical testing of tobacco products to assess the chemical profile of emissions is needed for evidence-based regulations. This testing has largely relied on targeted analytical methods that focus on constituent lists that may fall short in determining the toxicity of newly designed tobacco products. Nontargeted analysis (NTA), or the process of identifying and quantifying compounds within a complex matrix without prior knowledge of its chemical composition, is a promising technique for tobacco regulation, but it is not without challenges. The lack of standardized methods for sample generation, sample preparation, chromatographic separation, compound identification, and data analysis and reporting must be addressed so that the quality and reproducibility of the data generated by NTA can be benchmarked. This review discusses the challenges and highlights the opportunities of NTA in studying tobacco product constituents and emissions.

Indexed as

Tobacco ProductsReproducibility of ResultsTobacco Use

Identifiers

PMID37903095
PMCPMC13251346
OpenAlexW4388035219

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.